Early and Mid-Term Follow-up Results of Device Closure of Secundum Atrial Septal Defects Using Transesophageal Echocardiogram Guidance: A Comparison of Percutaneous Versus Peratrial Approaches
DOI:
https://doi.org/10.59958/hsf.7465Keywords:
transesophageal echocardiogram, percutaneous, peratrial, device closure, atrial septal defect, early and mid-termAbstract
Background: Percutaneous closure of secundum atrial septal defects (ASDs) under only transesophageal echocardiogram (TEE) guidance is less invasive and avoids exposure to radiation, but the treatment of choice is controversial. Methods: One hundred and forty-four patients with a secundum ASD were included in this study. The patients received percutaneous device closure (PCDC/TEE) (n = 74) or peratrial device closure (PDC/TEE) (n = 70). A double-disk ASD occluder was used in both groups. The treatment was performed under only TEE guidance in both groups. Physical exams, electrocardiography, and echocardiography were performed immediately after device release, and at discharge, 3, 6, 12 months, and at yearly intervals after the procedure. Results: In ASD with a maximum diameter less than 20 mm, the successful closure rate was 100% for all PCDC/TEE and PDC/TEE. When the ASD diameter was between 20 mm and 25 mm, the success rate was 84% for PCDC/TEE and 100% for PDC/TEE. The average intracardiac manipulation time was 19.4 ± 6.4 minutes for PCDC/TEE and 5.7 ± 7.0 minutes for PDC/TEE (p < 0.001). The average procedure time was 23.1 ± 6.8 minutes for PCDC/TEE and 51.1 ± 8.2 minutes for PDC/TEE (p < 0.001). The postoperative hospital stay was 3 ± 1 days for PCDC/TEE and 5 ± 1 days for PDC/TEE (p < 0.001). For the mean follow-up of 520 ± 256 days, there no cardiac deaths or significant residual shunts were documented in either group. Conclusions: In patients with an ASD less than 25 mm, PCDC/TEE is a safe and effective method of ASD closure. Additionally, PCDC/TEE is less traumatic, provides better cosmetic results, and decreases hospital stays. However, when the ASD diameter is greater than 20 mm and the aortic rim of ASD is less than 3 mm, the peratrial approach may be a better choice.
References
Bashir F, Hameed M, Hanif B, Aijaz S. Outcomes and complications of percutaneous device closure in adults with secundum atrial septal defect. JPMA. The Journal of the Pakistan Medical Association. 2022; 72: 385–389.
Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008; 118: e714–e833.
Olejnik P, Tittel P, Venczelova Z, Kardos M, Tomko J, Bartova M, et al. Long-term follow-up of percutaneous secundum-type atrial septal defect closure using Amplatzer Septal Occluder since 1995: a single-centre study. Cardiology in the Young. 2024; 34: 643–646.
King TD, Mills NL. Nonoperative closure of atrial septal defects. Surgery. 1974; 75: 383–388.
King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA. 1976; 235: 2506–2509.
Pan XB, Ou-Yang WB, Pang KJ, Zhang FW, Wang SZ, Liu Y, et al. Percutaneous Closure of Atrial Septal Defects Under Transthoracic Echocardiography Guidance Without Fluoroscopy or Intubation in Children. Journal of Interventional Cardiology. 2015; 28: 390–395.
Bartakian S, El-Said HG, Printz B, Moore JW. Prospective randomized trial of transthoracic echocardiography versus transesophageal echocardiography for assessment and guidance of transcatheter closure of atrial septal defects in children using the Amplatzer septal occluder. JACC. Cardiovascular Interventions. 2013; 6: 974–980.
Feltes TF, Bacha E, Beekman RH, 3rd, Cheatham JP, Feinstein JA, Gomes AS, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011; 123: 2607–2652.
Petit CJ, Justino H, Pignatelli RH, Crystal MA, Payne WA, Ing FF. Percutaneous atrial septal defect closure in infants and toddlers: predictors of success. Pediatric Cardiology. 2013; 34: 220–225.
Collins NJ, Hatton R, Ng K, Bhagwandeen R, Attia J, Oldmeadow C, et al. Percutaneous device closure of patent foramen ovale using the Premere occlusion device: initial experience, procedural, and intermediate-term results. The Journal of Invasive Cardiology. 2012; 24: 164–168.
Chen Q, Cao H, Zhang GC, Chen LW, Chen DZ. Safety and feasibility of intra-operative device closure of atrial septal defect with transthoracic minimal invasion. European Journal of Cardio-Thoracic Surgery. 2012; 41: 121–125.
Hongxin L, Lijun S, Wang ZJ, Zi J, Zhang WL, Zhang HZ, et al. Intraoperative device closure of large secundum atrial septal defects; a safe alternative to transcatheter closure. European Journal of Cardio-Thoracic Surgery. 2008; 33: 1055–1060.
Hongxin L, Wenbin G, Lijun S, Zhengjun W, Hao L, Chengwei Z, et al. Intraoperative device closure of secundum atrial septal defect with a right anterior minithoracotomy in 100 patients. The Journal of Thoracic and Cardiovascular Surgery. 2007; 134: 946–951.
Pinto R, Jain S, Dalvi B. Transcatheter closure of large atrial septal defects in children using the left atrial disc engagement-disengagement technique (LADEDT)-technical considerations and short term results. Catheterization and Cardiovascular Interventions. 2013; 82: 935–943.
Mylotte D, Quenneville SP, Kotowycz MA, Xie X, Brophy JM, Ionescu-Ittu R, et al. Long-term cost-effectiveness of transcatheter versus surgical closure of secundum atrial septal defect in adults. International Journal of Cardiology. 2014; 172: 109–114.
Harbron RW, Thierry-Chef I, Pearce MS, Bernier MO, Dreuil S, Rage E, et al. The HARMONIC project: study design for the assessment of radiation doses and associated cancer risks following cardiac fluoroscopy in childhood. Journal of Radiological Protection. 2020; 40.
Alvandi M, Narimani Javid R, Shaghaghi Z, Farzipour S, Nosrati S. An In-depth Analysis of the Adverse Effects of Ionizing Radiation Exposure on Cardiac Catheterization Staffs. Current Radiopharmaceuticals. 2024. (online ahead of print)
Jiang Y, Luo F, Bu H. Percutaneous closure of simple congenital heart diseases under echocardiographic guidance. European Journal of Medical Research. 2023; 28: 408.
Guo Z, Zhang C, Wang H, Ge S. Peratrial Device Closure of Atrial Septal Defect Under Transesophageal Echocardiographic Guidance without Fluoroscopy Compared to Conventional On-Pump Surgical Closure. Brazilian Journal of Cardiovascular Surgery. 2017; 32: 38–42.
Farhaj Z, Hongxin L, Wenbin G, Zhang WL, Liang F, Zhang HZ, et al. Device closure of diverse layout of multi-hole secundum atrial septal defect: different techniques and long-term follow-up. Journal of Cardiothoracic Surgery. 2019; 14: 130.
Abaci A, Unlu S, Alsancak Y, Kaya U, Sezenoz B. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies. Catheterization and Cardiovascular Interventions. 2013; 82: 1123–1138.
Himelfarb JD, Shulman H, Olesovsky CJ, Rumman RK, Oliva L, Friedland J, et al. Atrial fibrillation following transcatheter atrial septal defect closure: a systematic review and meta-analysis. Heart. 2022; 108: 1216–1224.
El-Sisi AM, El-Saiedi SA, Ammar R, Abdelhameed A, Hijazi ZM, Soliman MM. Safety of Occlutech Septal Occluder ACCELL Flex II for Transcatheter Closure of Secundum Atrial Septal Defects in Children: A Long-Term Follow-Up. Journal of Interventional Cardiology. 2022; 2022: 8886813.
Jalal Z, Hascoet S, Baruteau AE, Iriart X, Kreitmann B, Boudjemline Y, et al. Long-term Complications After Transcatheter Atrial Septal Defect Closure: A Review of the Medical Literature. The Canadian Journal of Cardiology. 2016; 32: 1315.e11–1315.e18.
